JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hiroshi Date
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yara, S.
Right arrow Articles by Date, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yara, S.
Right arrow Articles by Date, H.
Related Collections
Right arrow Lung - transplantation

J Thorac Cardiovasc Surg 2009;138:255-256
© 2009 The American Association for Thoracic Surgery

Letter to the Editor

Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation

Satomi Yara, MD, PhDa, Jiro Fujita, MD, PhDa, Hiroshi Date, MD, PhDb,c

a Department of Medicine and Therapeutics (First Department of Internal Medicine), Control and Prevention of Infectious Diseases, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
b Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
c Department of Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

The first 20% of the full text of this article appears below.

To the Editor:

Human T-lymphotropic virus type I (HTLV-I) is an etiologic agent for adult T-cell leukemia/lymphoma and HTLV-I–associated myelopathy/tropical spastic paraparesis. Most HTLV-I infections are attributable to transmission from mother to child or to sexual contact later in life, whereas transfusion is perhaps the most efficient mode of viral transmission. Seroprevalence of HTLV-1 among high-risk populations is 10% to 30% in the southern area of Japan, such as Okinawa, and approximately 5% in the Caribbean region compared with 1% in Europe and the United States.

There have been several reports of HTLV-1 transmission in association with . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.